155 related articles for article (PubMed ID: 33476929)
21. Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation.
Hakki M; Riddell SR; Storek J; Carter RA; Stevens-Ayers T; Sudour P; White K; Corey L; Boeckh M
Blood; 2003 Oct; 102(8):3060-7. PubMed ID: 12843000
[TBL] [Abstract][Full Text] [Related]
22. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
[TBL] [Abstract][Full Text] [Related]
23. Poor CMV-specific CD8+ T central memory subset recovery at early stage post-HSCT associates with refractory and recurrent CMV reactivation.
Liu J; Chang YJ; Yan CH; Xu LP; Jiang ZF; Zhang XH; Liu KY; Huang XJ
J Infect; 2016 Sep; 73(3):261-70. PubMed ID: 27311748
[TBL] [Abstract][Full Text] [Related]
24. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.
Tormo N; Solano C; Benet I; Clari MA; Nieto J; de la Cámara R; López J; López-Aldeguer N; Hernández-Boluda JC; Remigia MJ; Garcia-Noblejas A; Gimeno C; Navarro D
Bone Marrow Transplant; 2010 Mar; 45(3):543-9. PubMed ID: 19617905
[TBL] [Abstract][Full Text] [Related]
25. Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation.
Gerna G; Lilleri D; Fornara C; Comolli G; Lozza L; Campana C; Pellegrini C; Meloni F; Rampino T
Am J Transplant; 2006 Oct; 6(10):2356-64. PubMed ID: 16889599
[TBL] [Abstract][Full Text] [Related]
26. The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People.
Lim EY; Jackson SE; Wills MR
Front Cell Infect Microbiol; 2020; 10():202. PubMed ID: 32509591
[TBL] [Abstract][Full Text] [Related]
27. HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.
Quintela A; Escuret V; Roux S; Bonnafous P; Gilis L; Barraco F; Labussière-Wallet H; Duscastelle-Leprêtre S; Nicolini FE; Thomas X; Chidiac C; Ferry T; Frobert E; Morisset S; Poitevin-Later F; Monneret G; Michallet M; Ader F;
J Infect; 2016 Feb; 72(2):214-22. PubMed ID: 26518057
[TBL] [Abstract][Full Text] [Related]
28. Functional specific-T-cell expansion after first cytomegalovirus reactivation predicts viremia control in allogeneic hematopoietic stem cell transplant recipients.
Ciáurriz M; Beloki L; Zabalza A; Bandrés E; Mansilla C; Pérez-Valderrama E; Lachén M; Rodríguez-Calvillo M; Ramírez N; Olavarría E
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28921749
[TBL] [Abstract][Full Text] [Related]
29. Human cytomegalovirus load measurement and its applications for pre-emptive therapy in patients undergoing hematopoietic stem cell transplantation.
Baldanti F; Lilleri D; Gerna G
Hematol Oncol; 2008 Sep; 26(3):123-30. PubMed ID: 18386849
[TBL] [Abstract][Full Text] [Related]
30. Impaired T cells and "memory-like" NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation.
Lauruschkat CD; Muchsin I; Rein AF; Erhard F; Grathwohl D; Dölken L; Köchel C; Nehmer A; Falk CS; Grigoleit GU; Einsele H; Wurster S; Kraus S
Blood Adv; 2024 Jun; 8(11):2967-2979. PubMed ID: 38315873
[TBL] [Abstract][Full Text] [Related]
31. Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.
Neuenhahn M; Albrecht J; Odendahl M; Schlott F; Dössinger G; Schiemann M; Lakshmipathi S; Martin K; Bunjes D; Harsdorf S; Weissinger EM; Menzel H; Verbeek M; Uharek L; Kröger N; Wagner E; Kobbe G; Schroeder T; Schmitt M; Held G; Herr W; Germeroth L; Bonig H; Tonn T; Einsele H; Busch DH; Grigoleit GU
Leukemia; 2017 Oct; 31(10):2161-2171. PubMed ID: 28090089
[TBL] [Abstract][Full Text] [Related]
32. Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods.
Schermann CM; Fischer G; Witt V; Kurz M; Potschger U; Fritsch G
Cytotherapy; 2008; 10(8):834-41. PubMed ID: 19016371
[TBL] [Abstract][Full Text] [Related]
33. Clinical factors influencing phenotype of HCMV-specific CD8+ T cells and HCMV-induced interferon-gamma production after allogeneic stem cells transplantation.
Gayoso I; Cantisán S; Cerrato C; Sánchez-García J; Martin C; Solana R; Torres-Gomez A; Torre-Cisneros J
Clin Dev Immunol; 2013; 2013():347213. PubMed ID: 23424600
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study.
Serio B; Giudice V; Guariglia R; Fontana R; Pezzullo L; Martorelli MC; Ferrara I; Mettivier L; D'Addona M; Vaccaro E; Langella M; Selleri C
Infez Med; 2021 Mar; 29(1):102-113. PubMed ID: 33664179
[TBL] [Abstract][Full Text] [Related]
35. Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT.
Król L; Stuchlý J; Hubáček P; Keslová P; Sedláček P; Starý J; Hrušák O; Kalina T
Bone Marrow Transplant; 2011 Aug; 46(8):1089-98. PubMed ID: 21057553
[TBL] [Abstract][Full Text] [Related]
36. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
37. Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.
Huntley D; Giménez E; Pascual MJ; Remigia MJ; Amat P; Vázquez L; Hernández M; Hernández-Boluda JC; Gago B; Piñana JL; García M; Martínez A; Mateo E; Gozalbo-Rovira R; Albert E; Solano C; Navarro D
Bone Marrow Transplant; 2020 Jul; 55(7):1347-1356. PubMed ID: 32205853
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells.
Ozdemir E; St John LS; Gillespie G; Rowland-Jones S; Champlin RE; Molldrem JJ; Komanduri KV
Blood; 2002 Nov; 100(10):3690-7. PubMed ID: 12393402
[TBL] [Abstract][Full Text] [Related]
39. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
[TBL] [Abstract][Full Text] [Related]
40. Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Lee SM; Kim YJ; Yoo KH; Sung KW; Koo HH; Kang ES
Ann Lab Med; 2017 May; 37(3):277-281. PubMed ID: 28224776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
